IB
ANIP icon

Intrust Bank’s ANI Pharmaceuticals ANIP Stock Holding History

Intrust Bank’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,571
Closed -$221K – 312
2019
Q4 		$221K Sell
3,571
-79
-2% -$5.23K 0.05% 318
2019
Q3 		$266K Sell
3,650
-152
-4% -$11.4K 0.07% 286
2019
Q2 		$313K Sell
3,802
-64
-2% -$4.55K 0.08% 273
2019
Q1 		$273K Buy
+3,866
New +$227K 0.07% 312
2018
Q4 		– Sell
-3,623
Closed -$205K – 365
2018
Q3 		$205K Sell
3,623
-3,818
-51% -$234K 0.05% 354
2018
Q2 		$497K Buy
7,441
+545
+8% +$34K 0.14% 196
2018
Q1 		$402K Buy
6,896
+268
+4% +$17K 0.12% 234
2017
Q4 		$427K Buy
6,628
+1,018
+18% +$63.3K 0.13% 228
2017
Q3 		$295K Buy
5,610
+559
+11% +$26.7K 0.1% 292
2017
Q2 		$236K Buy
5,051
+535
+12% +$25.8K 0.08% 340
2017
Q1 		$223K Buy
+4,516
New +$254K 0.08% 344

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Intrust Bank's ANIP Position: Q1 2020 in Review

Intrust Bank sold out of ANI Pharmaceuticals (ANIP) in Q1 2020, closing a stake of 3,571 shares — an estimated $221K sold.

Intrust Bank first reported a position in ANIP in Q1 2017 and held it in 11 quarters. The position peaked at $497K in Q2 2018. 140 funds tracked by Wall St. Rank hold ANIP as of Q1 2020.

  • Intrust Bank reported no remaining ANI Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Intrust Bank sold 3,571 ANI Pharmaceuticals shares in Q1 2020, an estimated $221K.
  • Intrust Bank first reported a position in ANI Pharmaceuticals in Q1 2017 and held it in 11 quarters.
  • Intrust Bank's ANI Pharmaceuticals position peaked at $497K in Q2 2018.
  • 140 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2020.

Based on Intrust Bank's 13F filing for Q1 2020, filed 6 May 2020.